Report Detail
Global Fc Fusion Protein Drug Market Growth (Status and Outlook) 2022-2028
- RnM4495587 |
- 24 November, 2022 |
- Global |
- 104 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Fc-fusion proteins are bioengineered polypeptides that join the crystallizable fragment (Fc) domain of an antibody with another biologically active protein domain or peptide to generate a molecule with unique structure–function properties and significant therapeutic potential. The gamma immunoglobulin (IgG) isotype is often used as the basis for generating Fc-fusion proteins
The global market for Fc Fusion Protein Drug is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Fc Fusion Protein Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Fc Fusion Protein Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Fc Fusion Protein Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Fc Fusion Protein Drug market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Fc Fusion Protein Drug players cover Sanofi, Bristol-Myers Squibb, Regeneron, Bayer and Amgen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Fc Fusion Protein Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Fc Fusion Protein Drug market, with both quantitative and qualitative data, to help readers understand how the Fc Fusion Protein Drug market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Fc Fusion Protein Drug market and forecasts the market size by Type (Brands Drugs and Biosimilar Drugs,), by Application (Autoimmune Disease, Eye Diseases, Diabetes and Hemophilia), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Brands Drugs
Biosimilar Drugs
Segmentation by application
Autoimmune Disease
Eye Diseases
Diabetes
Hemophilia
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Sanofi
Bristol-Myers Squibb
Regeneron
Bayer
Amgen
Pfizer
Eli Lilly and Company
Sobi
Kanghong Pharma
3SBIO
Celgen Biopharma
Chapter Introduction
Chapter 1: Scope of Fc Fusion Protein Drug, Research Methodology, etc.
Chapter 2: Executive Summary, global Fc Fusion Protein Drug market size and CAGR, Fc Fusion Protein Drug market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Fc Fusion Protein Drug revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Fc Fusion Protein Drug revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Fc Fusion Protein Drug market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Sanofi, Bristol-Myers Squibb, Regeneron, Bayer, Amgen, Pfizer, Eli Lilly and Company, Sobi and Kanghong Pharma, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Fc Fusion Protein Drug Market Size 2017-2028
- 2.1.2 Fc Fusion Protein Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Fc Fusion Protein Drug Segment by Type
- 2.2.1 Brands Drugs
- 2.2.2 Biosimilar Drugs
- 2.3 Fc Fusion Protein Drug Market Size by Type
- 2.3.1 Fc Fusion Protein Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Fc Fusion Protein Drug Market Size Market Share by Type (2017-2022)
- 2.4 Fc Fusion Protein Drug Segment by Application
- 2.4.1 Autoimmune Disease
- 2.4.2 Eye Diseases
- 2.4.3 Diabetes
- 2.4.4 Hemophilia
- 2.4.5 Other
- 2.5 Fc Fusion Protein Drug Market Size by Application
- 2.5.1 Fc Fusion Protein Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Fc Fusion Protein Drug Market Size Market Share by Application (2017-2022)
3 Fc Fusion Protein Drug Market Size by Player
- 3.1 Fc Fusion Protein Drug Market Size Market Share by Players
- 3.1.1 Global Fc Fusion Protein Drug Revenue by Players (2020-2022)
- 3.1.2 Global Fc Fusion Protein Drug Revenue Market Share by Players (2020-2022)
- 3.2 Global Fc Fusion Protein Drug Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Fc Fusion Protein Drug by Regions
- 4.1 Fc Fusion Protein Drug Market Size by Regions (2017-2022)
- 4.2 Americas Fc Fusion Protein Drug Market Size Growth (2017-2022)
- 4.3 APAC Fc Fusion Protein Drug Market Size Growth (2017-2022)
- 4.4 Europe Fc Fusion Protein Drug Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Fc Fusion Protein Drug Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Fc Fusion Protein Drug Market Size by Country (2017-2022)
- 5.2 Americas Fc Fusion Protein Drug Market Size by Type (2017-2022)
- 5.3 Americas Fc Fusion Protein Drug Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Fc Fusion Protein Drug Market Size by Region (2017-2022)
- 6.2 APAC Fc Fusion Protein Drug Market Size by Type (2017-2022)
- 6.3 APAC Fc Fusion Protein Drug Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Fc Fusion Protein Drug by Country (2017-2022)
- 7.2 Europe Fc Fusion Protein Drug Market Size by Type (2017-2022)
- 7.3 Europe Fc Fusion Protein Drug Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Fc Fusion Protein Drug by Region (2017-2022)
- 8.2 Middle East & Africa Fc Fusion Protein Drug Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Fc Fusion Protein Drug Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Fc Fusion Protein Drug Market Forecast
- 10.1 Global Fc Fusion Protein Drug Forecast by Regions (2023-2028)
- 10.1.1 Global Fc Fusion Protein Drug Forecast by Regions (2023-2028)
- 10.1.2 Americas Fc Fusion Protein Drug Forecast
- 10.1.3 APAC Fc Fusion Protein Drug Forecast
- 10.1.4 Europe Fc Fusion Protein Drug Forecast
- 10.1.5 Middle East & Africa Fc Fusion Protein Drug Forecast
- 10.2 Americas Fc Fusion Protein Drug Forecast by Country (2023-2028)
- 10.2.1 United States Fc Fusion Protein Drug Market Forecast
- 10.2.2 Canada Fc Fusion Protein Drug Market Forecast
- 10.2.3 Mexico Fc Fusion Protein Drug Market Forecast
- 10.2.4 Brazil Fc Fusion Protein Drug Market Forecast
- 10.3 APAC Fc Fusion Protein Drug Forecast by Region (2023-2028)
- 10.3.1 China Fc Fusion Protein Drug Market Forecast
- 10.3.2 Japan Fc Fusion Protein Drug Market Forecast
- 10.3.3 Korea Fc Fusion Protein Drug Market Forecast
- 10.3.4 Southeast Asia Fc Fusion Protein Drug Market Forecast
- 10.3.5 India Fc Fusion Protein Drug Market Forecast
- 10.3.6 Australia Fc Fusion Protein Drug Market Forecast
- 10.4 Europe Fc Fusion Protein Drug Forecast by Country (2023-2028)
- 10.4.1 Germany Fc Fusion Protein Drug Market Forecast
- 10.4.2 France Fc Fusion Protein Drug Market Forecast
- 10.4.3 UK Fc Fusion Protein Drug Market Forecast
- 10.4.4 Italy Fc Fusion Protein Drug Market Forecast
- 10.4.5 Russia Fc Fusion Protein Drug Market Forecast
- 10.5 Middle East & Africa Fc Fusion Protein Drug Forecast by Region (2023-2028)
- 10.5.1 Egypt Fc Fusion Protein Drug Market Forecast
- 10.5.2 South Africa Fc Fusion Protein Drug Market Forecast
- 10.5.3 Israel Fc Fusion Protein Drug Market Forecast
- 10.5.4 Turkey Fc Fusion Protein Drug Market Forecast
- 10.5.5 GCC Countries Fc Fusion Protein Drug Market Forecast
- 10.6 Global Fc Fusion Protein Drug Forecast by Type (2023-2028)
- 10.7 Global Fc Fusion Protein Drug Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Sanofi
- 11.1.1 Sanofi Company Information
- 11.1.2 Sanofi Fc Fusion Protein Drug Product Offered
- 11.1.3 Sanofi Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Sanofi Main Business Overview
- 11.1.5 Sanofi Latest Developments
- 11.2 Bristol-Myers Squibb
- 11.2.1 Bristol-Myers Squibb Company Information
- 11.2.2 Bristol-Myers Squibb Fc Fusion Protein Drug Product Offered
- 11.2.3 Bristol-Myers Squibb Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Bristol-Myers Squibb Main Business Overview
- 11.2.5 Bristol-Myers Squibb Latest Developments
- 11.3 Regeneron
- 11.3.1 Regeneron Company Information
- 11.3.2 Regeneron Fc Fusion Protein Drug Product Offered
- 11.3.3 Regeneron Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Regeneron Main Business Overview
- 11.3.5 Regeneron Latest Developments
- 11.4 Bayer
- 11.4.1 Bayer Company Information
- 11.4.2 Bayer Fc Fusion Protein Drug Product Offered
- 11.4.3 Bayer Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Bayer Main Business Overview
- 11.4.5 Bayer Latest Developments
- 11.5 Amgen
- 11.5.1 Amgen Company Information
- 11.5.2 Amgen Fc Fusion Protein Drug Product Offered
- 11.5.3 Amgen Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Amgen Main Business Overview
- 11.5.5 Amgen Latest Developments
- 11.6 Pfizer
- 11.6.1 Pfizer Company Information
- 11.6.2 Pfizer Fc Fusion Protein Drug Product Offered
- 11.6.3 Pfizer Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Pfizer Main Business Overview
- 11.6.5 Pfizer Latest Developments
- 11.7 Eli Lilly and Company
- 11.7.1 Eli Lilly and Company Company Information
- 11.7.2 Eli Lilly and Company Fc Fusion Protein Drug Product Offered
- 11.7.3 Eli Lilly and Company Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Eli Lilly and Company Main Business Overview
- 11.7.5 Eli Lilly and Company Latest Developments
- 11.8 Sobi
- 11.8.1 Sobi Company Information
- 11.8.2 Sobi Fc Fusion Protein Drug Product Offered
- 11.8.3 Sobi Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Sobi Main Business Overview
- 11.8.5 Sobi Latest Developments
- 11.9 Kanghong Pharma
- 11.9.1 Kanghong Pharma Company Information
- 11.9.2 Kanghong Pharma Fc Fusion Protein Drug Product Offered
- 11.9.3 Kanghong Pharma Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Kanghong Pharma Main Business Overview
- 11.9.5 Kanghong Pharma Latest Developments
- 11.10 3SBIO
- 11.10.1 3SBIO Company Information
- 11.10.2 3SBIO Fc Fusion Protein Drug Product Offered
- 11.10.3 3SBIO Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 3SBIO Main Business Overview
- 11.10.5 3SBIO Latest Developments
- 11.11 Celgen Biopharma
- 11.11.1 Celgen Biopharma Company Information
- 11.11.2 Celgen Biopharma Fc Fusion Protein Drug Product Offered
- 11.11.3 Celgen Biopharma Fc Fusion Protein Drug Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Celgen Biopharma Main Business Overview
- 11.11.5 Celgen Biopharma Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Fc Fusion Protein Drug. Industry analysis & Market Report on Fc Fusion Protein Drug is a syndicated market report, published as Global Fc Fusion Protein Drug Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Fc Fusion Protein Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
